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Abstract  
Objective: Plasminogen activator inhibitor-2 (PAI-2) is an important counter 
proteolysis factor which helps protect tissues from inflammatory stress. The 
expression of PAI-2 can be modulated by various inflammatory stimulants and 
mediators. The aim of the present study was to investigate how serum factors, 
might modulate the effects of lipopolysaccharide (LPS) and interleukin-1b on 
PAI-2 production by human gingival fibroblasts. Methods: Human gingival 
fibroblasts were exposed to LPS derived from Actinobacillus 
actinomycetemcomitans or Escherichia coli and a commercial source of 
interleukin-1b (IL-1b). The expression of PAI-2 and its mRNA was monitored 
by Western blotting, RT-PCR, and Northern blotting. Results: The results 
showed that the distribution of PAI-2 synthesised by human gingival 
fibroblasts (HGF) was mostly as an intracellular protein (47kDa). The 
presence of serum in the culture media was absolutely necessary for both the 
secretion of PAI-2 and for the effect of the inflammatory mediators (LPS and 
IL-1b). A pattern of PAI-2 response in HGF after LPS stimulation was 
detected with a quick up-regulation of the PAI-2 mRNA, which was down 
regulated when extracellular PAI-2 (60kDa mass) levels reached plateau 
levels. The synthesis of PAI-2 by HGF, in terms of mRNA expression and 
protein synthesis, was more sensitive to stimulation with lower concentrations 
of LPS (10ng/ml) than with higher LPS concentrations. Conclusions: PAI-2 is 
a serum dependent molecule with major cytosolic localisation in HGF. Its 
cellular accumulation and secretion can be modulated by bacterial LPS and 
IL-1b through serum factors.  
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